New studies posted this week in Arthritis & Rheumatology:
Adalimumab ± MTX as first-line therapy for childhood-onset chronic uveitis
https://t.co/L4QiZZBBG7
Bisphosphonates & PPI/H2RA coprescriptions in polymyalgia rheumatica
https://t.co/62Pqt5Ab58
Phase 3b SOLSTICE trial: https://t.co/MsK4XC3eNh
Links:
Treatment of a large cohort of childhood chronic non‐infectious uveitis a multi…
https://doi.org/10.1002/art.70090
Prescribing of medication to prevent glucocorticoid harms in patients with Poly…
https://doi.org/10.1002/art.70087
Feb-21-2026
